Breast cancer laboratory tests

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Breast Cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Breast cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT scan

MRI

Echocardiography or Ultrasound

Other Imaging Studies

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Breast cancer laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Breast cancer laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Breast cancer laboratory tests

CDC on Breast cancer laboratory tests

Breast cancer laboratory tests in the news

Blogs on Breast cancer laboratory tests

Directions to Hospitals Treating Breast cancer

Risk calculators and risk factors for Breast cancer laboratory tests

Laboratory Findings

The goals of breast cancer testing are to identify genetic risk in high risk women, detect and diagnose breast cancer in its earliest stages, determine how far it has spread, evaluate the cancer's characteristics in order to guide treatment, monitor the effectiveness of treatment, and monitor the person over time to detect and address any cancer recurrences. The tissue samples required for some of the tests may involve a needle biopsy, in which cells from the breast are aspirated through a needle into a syringe, or by surgically removing some breast tissue or a tumor (open biopsy)

Laboratory tests for breast cancer can be broken down into groups, based on the purpose of testing:

  • To determine genetic risk in high risk women: blood testing for mutations that may be present in the BRCA-1 and BRCA-2genes
  • To diagnose: cytology - a microscopic examination of tumor cells obtained through fine needle aspiration and surgical pathology - a microscopic examination of tissue sampling via biopsy
  • To determine treatment options: evaluation of the tumor's HER-2/neugene amplification status and estrogen and progesterone receptor status
  • To monitor treatment and for recurrence: measurement of CA 15-3 or CA 27.29 in the blood

Some tests for breast cancer are performed on the woman's blood; others are done on a sample of cells or the tumor tissue.

Tests for Breast Cancer

TEST DESCRIPTION TEST SAMPLE
BRACA-1/BRACA-2 Genetic markers, if present, suggest an 80% likelihood of breast cancer occurrence. Blood
Her 2/neu A test for specific proteins; tumors with increased levels may respond well to a medication called Herceptin(Trastuzumab). Tissue
Her-2/neu(blood) After an initial diagnosis of metastatic breast cancer is made, this blood test may be performed and, if the initial level is greater than 15 ng/mL, then the test may be used to monitor treatment. Blood
Estrogen Receptor/Progesterone Receptor Increased levels suggest a good response to hormonal therapy. Hormonal therapy is not the same as hormone replacement therapy (HRT) and presence of these receptors does not indicate that HRT caused the cancer. Tissue
CA15-3/ CA27.29 Elevated blood levels of cancer antigens may indicate recurrence of cancer. Blood
Oncotype DX May assist in determining risk of recurrence and predict who will benefit from hormone therapy or chemotherapy. Tissue
MammaPrint May assist in determining whether a woman is at risk of recurrence of cancer, to help guide treatment. Tissue

References

Template:WH Template:WS